Clinical trials
Waldenstrom Macroglobulinemia trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Kite, A Gilead Company | 1 |
| Loxo Oncology, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Nurix Therapeutics, Inc. | 1 |
| Swiss Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Lymphoma, B-Cell, Marginal Zone | 7 |
| Lymphoma, Follicular | 7 |
| Lymphoma, Mantle-Cell | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Burkitt Lymphoma | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Leukemia, Hairy Cell | 5 |
| Lymphoma, Large-Cell, Immunoblastic | 5 |
Trials
Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.